International, prospective, double-blind, 3-arm comparative, randomized, placebo controlled phase IV study on the effect of counseling and either tranexamic acid or mefenamic acid or placebo, on the management of bleeding/spotting in women using the levonorgestrel-releasing intrauterine system (MIRENA) for contraception.

Trial Profile

International, prospective, double-blind, 3-arm comparative, randomized, placebo controlled phase IV study on the effect of counseling and either tranexamic acid or mefenamic acid or placebo, on the management of bleeding/spotting in women using the levonorgestrel-releasing intrauterine system (MIRENA) for contraception.

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Dec 2014

At a glance

  • Drugs Levonorgestrel (Primary) ; Mefenamic acid; Tranexamic acid
  • Indications Metrorrhagia
  • Focus Therapeutic Use
  • Sponsors Bayer HealthCare
  • Most Recent Events

    • 21 Apr 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
    • 15 Mar 2012 Planned end date 1 Jan 2012 added as reported by EudraCT.
    • 15 Mar 2012 This trial has been completed in Ireland.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top